NEONC TECHNOLOGIES HOLDINGS, INC.: Cinctive Capital Management LP amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Cinctive Capital Management LP amended its Schedule 13G filing on NEONC Technologies Holdings, Inc., updating its beneficial ownership stake with the SEC under accession number 0000905148-26-004936. The amendment signals a change in the hedge fund's position in the clinical-stage biotech, though the filing did not disclose specific share counts or percentage moves in the headline. Schedule 13G amendments are typically filed when a passive investor's ownership crosses the 5% threshold or when previously reported holdings change materially. Investors will watch for the full filing details to gauge whether Cinctive increased or trimmed its exposure to NEONC's intranasal brain-cancer drug platform.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
NEONC TECHNOLOGIES HOLDINGS, INC., Cinctive Capital Management LP